Alternatives to Eleven Therapeutics
Eleven Therapeutics is a Healthcare tool: israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Healthcare companies to Eleven Therapeutics
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Alnylam Pharmaceuticals19BiotechnologyCambridge, United StatesBiopharmaceutical company pioneering RNA interference (RNAi) therapeutics to treat rare and prevalent genetic diseases.
- Website
Immunai69HealthcareNew York, United States$295.0MMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
- Website
FORE Biotherapeutics56HealthcarePhiladelphia, United States$232.4MPrecision oncology company developing cancer therapies guided by proprietary functional genomics.
- Website
Wild Biotech38HealthcareCambridge, United StatesTherapeutics company developing novel treatments for complex diseases.
- Website
Sequentify48HealthcareSan Francisco, United States$7.0MMaking targeted DNA sequencing as common, fast, and affordable as a blood test.
- Website
VILYA62BIO + LIFE SCIENCESSan Francisco, United States$121.0MAI-powered platform for designing novel molecular structures for new medicines.
- Website
Epicrispr Biotechnologies62BiotechnologySouth San Francisco, United States$90.0MEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
- Website
Mana.bio59Life SciencesBoston, United States$19.5MAI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.
- Website
Avidity Biosciences53BiotechSan Diego, United States$495.0MClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
- Website
Adaptam Therapeutics53BiotechCambridge, United States$4.7MDeveloping novel therapeutics for rare genetic diseases with a focus on protein degradation.
- Website
ZipBio52Life SciencesCambridge, United States$4.0MCompressing biology to develop the next generation of therapies.
- Website
1E Therapeutics48Drug Development$120.0MDrug development company creating first-in-class RNA-targeting therapeutics using a proprietary platform.
- Website
CytoReason68HealthcareTel Aviv, Israel$128.3MDevelops a computational model of the human body for drug discovery and development.
- Website
DPEEX52HealthcareAI-powered multi-omics platform for early breast cancer detection and risk prediction.
- Website
Beam Therapeutics47WorkflowsCambridge, United States$235.0MA biotechnology company developing precision genetic medicines through base editing technology to treat a broad range of diseases.
- Website
Nucleai63HealthcareTel Aviv, Israel$58.5MAI-powered spatial biology platform for precision medicine and drug development.
- Website
Variantyx63HealthcareFramingham, United States$74.5MVariantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.
- Website
DeepCure63HealthcareTel Aviv, Israel$65.4MAI-driven drug discovery platform accelerating breakthrough scientific research.
- Website
Ukko62HealthcarePalo Alto, United States$40.0MUkko is developing novel food allergy and disorder treatments using advanced immunology and plant science.
Showing the 20 closest matches. See the rest on the Eleven Therapeutics profile.
Compare Eleven Therapeutics head to head
Side by side on what each one does, what it costs, and what real users report.